SASabri Abuş

Sabri Abuş

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sabri Abuş has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prognostic value of the endothelial activation and stress index (EASIX) for in-hospital and overall mortality in patients undergoing transcatheter aortic valve implantation

    by Kadir Biyikli, Sabri Abus, Mustafa Kara, Ayşenur Kucuk, Cemil Can, Hasan Karaot, Omer Doğukan Ertan, Çağrı Kafkas

    Patients undergoing transcatheter aortic valve implantation (TAVI) are typically elderly with multiple comorbidities, making accurate preprocedural risk stratification essential. The Endothelial Activation and Stress Index (EASIX), calculated from lactate dehydrogenase, creatinine, and platelet count, reflects endothelial injury and systemic stress, however, its incremental prognostic value beyond established risk markers in TAVI populations has not been fully characterized.This study aimed to evaluate the association between preprocedural EASIX and both in-hospital and overall mortality after TAVI. This retrospective cohort study included 742 consecutive patients who underwent TAVI for symptomatic severe aortic stenosis between January 2020 and January 2025. EASIX was calculated from laboratory parameters obtained 48-72 h before the procedure, and patients were stratified into tertiles. The primary outcome was overall mortality; in-hospital mortality was the secondary outcome. Cox proportional hazards and logistic regression analyses identified independent predictors. Incremental prognostic value was evaluated using Harrell's C-index, continuous Net Reclassification Improvement (NRI), and Integrated Discrimination Improvement (IDI), and survival was assessed by Kaplan-Meier analysis. The median age was 78 years (IQR 74-83), and 56.2% were female. During a median follow-up of 345 days, overall mortality occurred in 119 patients (16.0%) and in-hospital mortality in 63 (8.5%). Patients in the highest EASIX tertile had higher in-hospital (15.4%) and overall mortality (25.9%) than lower tertiles (p < 0.001). One-year survival was 87.4%, 93.4%, and 78.1% across tertiles 1-3, respectively (log-rank p < 0.001). EASIX independently predicted overall mortality (HR 1.21 per unit, 95% CI 1.07-1.38; p = 0.003) and in-hospital mortality (OR 1.29, 95% CI 1.05-1.59; p = 0.016). Adding EASIX to a base model (age, sex, LVEF, lnBNP) significantly improved reclassification for both endpoints (NRI = 0.314 and 0.357; IDI = 0.022 and 0.019; all p < 0.05). Preprocedural EASIX is independently associated with both in-hospital and overall mortality after TAVI and provides incremental reclassification beyond established clinical and biomarker variables. As an easily obtainable index from routine laboratory parameters, EASIX may serve as a simple and practical tool for preprocedural risk stratification, complementing rather than replacing established biomarkers such as BNP. Prospective multicenter studies are needed to validate these findings.


  • Open Access

    Assessment of serum caveolin-3 levels in patients with heart failure

    by Ahmet Süsenbük, Hakan Kaya, Sabri Abuş, Abdulmecit Afşin

    Background: Heart failure (HF) is a complex syndrome caused by structural and functional abnormalities that impair ventricular filling and ejection. Caveolin-3 (Cav-3), a muscle-specific membrane protein, is essential for T-tubule formation and maintenance in cardiomyocytes. Although caveolin deficiency leads to severe cardiac phenotypes, Cav-3's specific mechanistic role in chronic HF remains insufficiently defined.Objective: The principal objective of this investigation was to assess serum Cav-3 concentrations in patients diagnosed with chronic HF.Methods: This case-control study encompassed 90 participants, comprising 45 individuals with chronic HF (HF group) and 45 age- and sex-matched healthy controls (non-HF group). Blood specimens were obtained from both groups, and Cav-3 concentrations were quantified utilizing the enzyme-linked immunosorbent assay (ELISA) methodology. In addition, all participants underwent comprehensive transthoracic echocardiography (TTE). Both echocardiographic and laboratory parameters, including Cav-3 levels, were systematically compared between the two cohorts.Results: Among 90 participants (45 HF; 45 matched controls), HF patients showed typical adverse remodeling [LVEF 35% [20–50] vs. 60% [55–65], p < 0.001] and higher inflammatory/coagulation activity. Median serum Cav-3 was higher in HF than controls [4.83 [4.34–5.60] vs. 3.97 [3.30–4.96] ng/L; p < 0.001]. On ROC analysis, NT-proBNP provided the strongest single-marker discrimination (AUC 0.850; cutoff 254.50 pg/ml; sensitivity 79.5%; specificity 80.0%), Cav-3 alone showed moderate accuracy (AUC 0.705; cutoff 4.36 ng/L; sensitivity 75.0%; specificity 73.3%), and the Cav-3 + NT-proBNP combination achieved the highest AUC (0.878; sensitivity 81.8%; specificity 84.4%; p < 0.001). In multivariable models predicting EF, WBC, NT-proBNP, and ESR were independent negative predictors, whereas Cav-3 was not significant after adjustment. Cav-3 concentrations were higher in HFrEF and HFmrEF vs. controls, with no difference between HF subgroups.Conclusions: Serum Cav-3 is elevated in chronic HF and enhances diagnostic discrimination when added to NT-proBNP, but does not independently predict EF after adjustment. These findings support Cav-3 as an adjunctive—rather than stand-alone—biomarker within a multimarker strategy. Prospective multicenter studies should validate reproducibility, define clinically actionable thresholds, and quantify incremental value over natriuretic peptide–based and multimarker baselines.

  • Open Access

    Clozapine-Induced Cardiac Tamponade: A Rare Cause of Chest Pain

    by Yaşar Kapıcı, Dilek Örüm, Sabri Abuş, Olga Bayar Kapıcı

    We found that a patient with cardiac tamponade, a rare reaction to clozapine used in treatment-resistant schizophrenia patients, had a remission of this side effect after discontinuation of the drug.

  • Open Access

    Cardiovascular Risk Profiles of Individuals with Bruxism: A Case-Control Study Using QRISK3 Scores

    by Tolga Bayar, Sezer Markirt, Kadir Bıyıklı, Veysi Kavalcı, Mehmet Bozkurt, Mustafa Utkun, Erkan Markirt, Deniz Merde Özdemir, Sabri Abuş

    Introduction: Bruxism has been linked to autonomic dysregulation and systemic inflammation-mechanisms that may elevate cardiovascular disease (CVD) risk. However, no study to date has applied a validated risk‐prediction model to quantify this risk in bruxism patients. This study aims to compare 10-year CVD risk, as estimated by the QRISK3 algorithm, between adults with bruxism and matched controls, and to assess the relationship between bruxism severity and cardiovascular risk. Methods: We conducted a cross‐sectional, matched case-control study recruiting 92 adults (25-65 years) with clinically diagnosed bruxism and 108 non-bruxing controls matched for age (±2 years), sex, body‐mass index (BMI) (±1 kg/m²), smoking status, hypertension, and diabetes. Bruxism severity was measured via the eight-item Bruxism Severity Questionnaire (BSQ). Ten-year CVD risk was calculated using QRISK3 inputs from clinical history, physical examination, and recent laboratory values. Results: Cases and controls did not differ in mean age (42.5 ± 10.3 vs. 41.8 ± 9.7 years; p=0.63), sex distribution (55% female each), BMI (26.2 ± 3.4 vs. 25.8 ± 3.1 kg/m²; p=0.315), smoking (23.9% vs. 18.5%; p=0.756), hypertension (15.2% vs. 11.1%; p=0.698), or diabetes (8.7% vs. 5.5%; p=0.564). The mean QRISK3 score was higher in bruxers than controls (8.2 ± 4.5 % vs. 6.1 ± 3.7 %; t=4.156, p<0.001), and the prevalence of “high CVD risk” was 28.3 % vs. 14.8 % (χ²=6.102, p=0.013). The BSQ total score correlated moderately with QRISK3 (r=0.36, p<0.001). After adjustment for age, sex, BMI, smoking, hypertension, diabetes, and hyperlipidemia, bruxism remained an independent predictor of high CVD risk (OR 2.30; 95% CI 1.15-4.58; p=0.019). Conclusion: Adults with bruxism exhibit significantly higher estimated 10-year CVD risk than matched controls, and bruxism severity correlates with QRISK3. These findings support the integration of cardiovascular risk screening in dental practice for patients presenting with bruxism.

  • Open Access

    Effect of Dapagliflozin Treatment on Index of Cardiac Electrophysiological Balance in Patients With Heart Failure With Reduced Ejection Fraction

    by Yusuf Kayhan, Hakan Kaya, Veysi Kavalci, Sabri Abus, Kadir Biyikli, Sezer Markirt, Cemil Can, Erkan Markirt, Deniz Merde Özdemir

    Background: Dapagliflozin (DAPA), a sodium‐glucose cotransporter‐2 (SGLT2) inhibitor, may attenuate the risk of ventricular arrhythmia (VA) through its antiarrhythmic properties in patients with heart failure with reduced ejection fraction (HFrEF). The antiarrhythmic mechanisms of SGLT2 inhibitors are not fully known. Recently, the index of cardiac electrophysiological balance (ICEB) has been posited as a robust indicator for predicting VA risk. ICEB reflects the balance between ventricular depolarization and repolarization. This study was conducted to investigate the effects of DAPA treatment on ICEB in a cohort of patients with HFrEF.Methods: A total of 235 HFrEF patients undergoing DAPA treatment were enrolled in the study. Each participant underwent a comprehensive 12‐lead electrocardiography (ECG) assessment prior to treatment initiation and approximately 6 months posttreatment. ICEB values were compared before and after treatment.Results: The analysis revealed a statistically significant reduction in the QT interval (427.51 ± 13.87 vs. 347.75 ± 11.21 ms, p < 0.001), corrected QT interval (QTc) (458.34 ± 29.71 vs. 393.37 ± 13.21 ms, p < 0.001), T peak‐to‐end (Tp‐e) interval (85.41 ± 3.52 vs. 71.18 ± 3.16 ms, p < 0.001), Tp‐e/QTc ratio (0.186 ± 0.009 vs. 0.180 ± 0.003, p < 0.001), ICEB (4.59 ± 0.65 vs. 3.77 ± 0.15, p < 0.001), following approximately 6 months of DAPA treatment.Conclusion: In addition to ventricular repolarization distribution indices, the regression of the ICEB values after DAPA treatment in patients with HFrEF shows that DAPA treatment improves the balance between ventricular depolarization and repolarization and reduces the risk of VA in these patients.


  • Open Access

    Ten-year cardiovascular disease risk and related factors in lifetime marijuana use with comorbid methamphetamine-associated psychotic disorder: a QRISK®3 study

    by Dilek Örüm, Mehmet Hamdi Örüm, Yaşar Kapıcı, Sabri Abuş

    Methamphetamine use and related direct and indirect problems are increasing all over the world. The coexistence of lifetime marijuana use (LMU) and methamphetamine use disorder (MUD) may also be accompanied by psychotic symptoms (MAP). Methamphetamine and marijuana use are known to pose risks for cardiovascular diseases (CVDs). However, ten-year CVD risk and inflammation markers of LMU-MUD (non-psychosis group) and LMU-MAP (psychosis group) subjects and the relationship of various sociodemographic and clinical variables with these markers have not yet been examined. Thirty-two male subjects were included in non-psychosis group and 72 male subjects in psychosis group. Sociodemographic and clinical characteristics were recorded. Psychotic symptom severity of psychosis group subjects was measured. The ten-year CVD risk was calculated using QRISK®3 model. Age, cigarettes/pack-years, alcohol use onset age, drug use onset age, methamphetamine use onset age, duration of methamphetamine use, education and marital status of the groups were similar (p > 0.05). There was a statistical difference between the non-psychosis and psychosis groups in terms of self-mutilation history (p < 0.001), suicidal attempt history (p = 0.007), homicidal attempt history (p = 0.002), psychiatric hospitalization history (p = 0.010). Ten-year QRISK®3 score was 4.90 ± 9.30 in the psychosis group, while it was 1.60 ± 1.43 in the non-psychosis group (p = 0.004). The mean heart age of the psychosis group was 14 years higher than their chronological age, while the mean heart age of the non-psychosis group was 8 years higher. Neutrophil to lymphocyte ratio (NLR) (p = 0.003) was higher in the psychosis group. A significant correlation was detected between ten-year QRISK®3 and positive psychotic symptoms in the psychosis group (r = 0.274, p = 0.020). Regression analysis showed that self-mutilation history, NLR and relative risk obtained from QRISK®3 can be used to distinguish non-psychosis group and psychosis group subjects (sensitivity = 91.7; Nagelkerke R2 0.438; p = 0.001). This study is important as it demonstrates for the first time that among the subjects using marijuana and methamphetamine, those with psychotic symptoms have a higher NLR and ten-year CVD risk.


  • Open Access

    Relationship Between Pulmonary Artery Pressure and Inflammation Parameters

    by Sabri Abuş

    Background Inflammation can play a role in the development and progression of pulmonary hypertension (PHT). In this study, inflammatory parameters were compared in congestive heart failure (CHF) patients with and without PHT. The relationship between pulmonary artery pressure (PAP) and inflammatory parameters was investigated. Materials and methods Out of 80 CHF patients, 40 had PHT. The patients' age, gender, smoking status, comorbidities such as diabetes mellitus (DM) and hypertension (HT), and mortality rates were recorded. Inflammatory parameters were recorded. Results The mean age of the PHT group was 64.38 +/- 9.17 and the mean age of the non-PHT group was 64.70 +/- 8.99. There were 23 men and 17 women in the PHT group, and there were 21 men and 19 women in the non-PHT group. There was no significant difference between the two groups in terms of mean age and gender distribution (p = 0.874 and p = 0.653). Accordingly, the C -reactive protein to albumin ratio (CAR) value was statistically significantly higher in PHT patients (p = 0.023). The eosinophil count was found to be significantly higher in non-PHT patients (p = 0.015). Accordingly, a significant correlation was detected between CAR and PAP (r = 0.392 and p < 0.001). Conclusion In this study, the positive correlation between PAP and CAR and the significantly higher CAR value in PHT patients indicate the presence of inflammation in PHT patients. Studies on the relationship between inflammation and mortality in PHT patients may contribute more to the literature in the future.

  • Open Access

    Investigation of carotid intima-media thickness in patients with schizophrenia

    by Yaşar Kapıcı, Olga Bayar Kapıcı, Sabri Abuş, Mehmet Hamdi Örüm, Selçuk Ayhan, Mehmet Bozkurt, Bilal Özer, Atilla Tekin

    Background: Patients with schizophrenia (SCZ) have a higher risk of cardiovascular diseases than the average population. Early diagnosis of SCZ patients with subclinical atherosclerosis is great importance in reducing cardiovascular morbidity and mortality. The aim of this study was to investigate some clinical risk factors for atherosclerosis in patients with SCZ. Methods: Fifty-one SCZ patients (20 females, 31 males) and 55 healthy controls (HCs) (25 females, 30 males) were included in the study. Electrocardiography (ECG), lipid parameters, hemogram, and biochemistry values of the participants were taken. Low-density lipoprotein (LDL), high-density lipoprotein (HDL), fasting triglycerides, and total cholesterol were measured. The arrhythmogenic index of plasma (AIP) was analyzed. The recorded right and left carotid intima-media thickness (CIMT) measurements by carotid ultrasonography were scanned. Results: QT interval (p = 0.035), CIMT-left (p = 0.008), CIMT-right (p = 0.002), fasting triglyceride (p = 0.005), AIP (p = 0.005) in the SCZ group compared to HCs (< 0.001) was statistically higher, while HDL (p = 0.003) was statistically lower. Smoking rates, QT interval (p = 0.035), CIMT-left (p = 0.008), and CIMT-right (p = 0.002) were significantly higher in the the SCZ group than in the HCs. According to odds ratios, individuals with SCZ have a 6.3-fold higher smoking rate. According to Pearson correlation analysis, CIMT-left was positively correlated with age and QT interval (r = 0.568, p < 0.001 and r = 0.589, p < 0.001, respectively). CIMT-right value was also positively correlated with age and QT interval (r = 0.533, p < 0.001 and r = 0.555, p < 0.001, respectively). QT interval positively and significantly predicted CIMT-left and CIMT-right (p < 0.001, β = 0.549 and p = 0.001 and β = 0.506 accordingly). Conclusion: In this study, a close relationship was found between the QT interval and CIMT in SCZ patients. This finding could be valuable for using an easy-to-calculate data such as QT in place of a laborious test such as CIMT.


  • Open Access

    C-reactive protein to albumin ratio in atrial fibrillation

    by Sabri Abuş

    Objectives: Atrial fibrillation (AF) may cause thromboembolism and cardiac morbidity and mortality. Patients with cardiovascular diseases are at risk for developing AF. In this study, the relationship between inflammation markers and AF was examined. Methods: Among 689 people followed up in the cardiology outpatient clinic for reasons such as hypertension, coronary artery disease, and rheumatic valve disease, 88 patients with AF and 601 patients without AF were compared. The blood parameters of the AF group were examined during the period when AF developed in the patients. Hemogram and biochemistry parameters of AF and non-AF groups were compared. Results: C-reactive protein to albumin ratio (CAR), neutrophil count to albumin ratio, neutrophil count to lymphocyte count ratio, and monocyte count to lymphocyte count ratio were significantly higher in the AF group than in the non-AF group (p < 0.001, p < 0.001, p = 0.001, and p < 0.001; respectively). According to the Receiver Operating Characteristics analysis, it was found that the CAR value of cut-off: 0.0533 could diagnose AF with 74% sensitivity (AUC: 0.789, CI 95%: 0.726-0.853, p < 0.001). Albumin value of cut-off: 3.75 was found to be able to diagnose AF with 82% specificity (AUC: 0.772, CI 95%: 0.707-0.836, p < 0.001). Conclusions: AF is an arrhythmia that should be recognized early due to the complications it causes, and the CAR value can be used in the diagnosis of AF in individuals with cardiac disease.


  • Open Access

    Comparison of Platelet Parameters and Electrocardiogram Data in Patients with Generalized Anxiety Disorder with Healthy Control Group

    by Yaşar KAPICI, Sabri Abuş, Selçuk Ayhan, Hakan Ti̇bİlLi̇, Ahmet Akçay

    Aim: Generalized anxiety disorder (GAD) refers to the intense stress and tension felt in the face of various life events. Various studies have shown that cardiovascular diseases are more common in patients with anxiety. Frontal QRS-T (fQRS-T) has been shown to be elevated in cardiovascular diseases. In this study, the fQRS-T, hemogram, and biochemistry values of patients with GAD were compared with healthy controls (HC) and the cardiovascular risk status of GAD patients was evaluated. Material and Methods: Seventy patients with a diagnosis of GAD and no comorbidity followed in the district state hospital's psychiatry outpatient clinic were included in this study. Sociodemographic data, disease severity, hemogram, biochemistry values, electrocardiogram (ECG) data of these patients were recorded. Disease severity was evaluated with The Generalized Anxiety Disorder Test-7 (GAD-7). These values were compared with 80 HCs without any psychiatric or organic disease. The correlation of fQRS-T value with platelet parameters and age was investigated in GAD patients. Results: According to the statistical analysis, fQRS-T was wider in patients with GAD than in HC (p<.001). Accordingly, basophil count was statistically lower in patients with GAD (p<.001). Eosinophil count and mean platelet volume (MPV) were significantly elevated in patients with GAD (p=.019 and p=.003 respectively). Accordingly, fQRS-T and MPV are highly correlated (p<.001). The GAD-7 score and fQRS-T were positively correlated (p=.001). According to the linear regression analysis for fQRS-T, MPV and GAD-7 scores positively and significantly predict fQRS-T (p<.001 and p=.036 respectively). Conclusion: This study is the first in the literature to examine fQRS-T in patients with GAD. In this study, we discovered that MPV predicts fQRS-T in GAD. Future studies are essential in predicting cardiovascular risk using methods demonstrating platelet dysfunction in anxiety disorders.